Answers are grounded in this paper and cite their sources.
Retrospective trial evaluated outcomes of endoscopic papillectomy in patients with adenoma and FAP, indicating potential recurrence risks.
This retrospective single-center trial [1] included 51 patients treated by endoscopic papillectomy (EP): 11 familial adenomatous polyposis (FAP), 35 sporadic adenoma/adenocarcinoma lesions (SAL), and five non-adenomatous lesions. The authors aimed to evaluate predictors for recurrence and adverse events (AEs). In addition, they compared baseline characteristics and outcomes between patients with FAP vs SAL. The conclusions of this trial must be compared with results of large trials and guidelines recently published.
No takes yet. Share an insight, caveat, or question.
Bertrand Napoléon (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: